AI-assisted, human-published
01/29/2026 /Funding Events
CraniUS Therapeutics Secures $20 Million for Breakthrough Brain Drug Delivery Platform
CraniUS Therapeutics raises $20 million in Series B financing to accelerate the development of NeuroPASS™, a fully implantable platform designed to bypass the blood-brain barrier for targeted drug delivery in the brain.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com